Advertisement

Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia

Nicola Gökbuget, Hervé Dombret, Massimiliano Bonifacio, Albrecht Reichle, Carlos Graux, Christoph Faul, Helmut Diedrich, Max S. Topp, Monika Brüggemann, Heinz-August Horst, Violaine Havelange, Julia Stieglmaier, Hendrik Wessels, Vincent Haddad, Jonathan E. Benjamin, Gerhard Zugmaier, Dirk Nagorsen and Ralf C. Bargou
This article has an Erratum 133(24):2625

Article Information

Citation 
vol. 131 no. 14 1522-1531
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted August 10, 2017
  • Accepted January 16, 2018
  • Published online April 5, 2018.

Article Versions


Contributors 
  • Nicola Gökbuget, 1University Hospital, Frankfurt, Germany;
  • Hervé Dombret, 2University Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, University Paris Diderot, Paris, France;
  • Massimiliano Bonifacio, 3Department of Medicine, Section of Hematology, Verona University, Verona, Italy;
  • Albrecht Reichle, 4University Hospital Regensburg, Regensburg, Germany;
  • Carlos Graux, 5Université Catholique de Louvain, CHU UCL Namur (Godinne), Yvoir, Belgium;
  • Christoph Faul, 6University Hospital and Comprehensive Cancer Center Tübingen, Universitätsklinikum Tübingen, Tübingen, Germany;
  • Helmut Diedrich, 7Department of Hematology and Oncology, Medizinische Hochschule, Hannover, Germany;
  • Max S. Topp, 8Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany;
  • Monika Brüggemann, 9Klinik für Innere Medizin II, Universitätsklinikum Schleswig-Holstein, Kiel, Germany;
  • Heinz-August Horst, 9Klinik für Innere Medizin II, Universitätsklinikum Schleswig-Holstein, Kiel, Germany;
  • Violaine Havelange, 10Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium;
  • Julia Stieglmaier, 11Amgen Research (Munich), GmbH, Munich, Germany;
  • Hendrik Wessels, 11Amgen Research (Munich), GmbH, Munich, Germany;
  • Vincent Haddad, 12Amgen, Ltd., Cambridge, United Kingdom;
  • Jonathan E. Benjamin, 13Amgen, Inc., Thousand Oaks, CA; and
  • Gerhard Zugmaier, 11Amgen Research (Munich), GmbH, Munich, Germany;
  • Dirk Nagorsen, 13Amgen, Inc., Thousand Oaks, CA; and
  • Ralf C. Bargou, 14Comprehensive Cancer Center Mainfranken, Uniklinikum Würzburg, Würzburg, Germany

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output